topics


Medical Safety

What Is Your Antibiotics IQ?
Other Resource

What Is Your Antibiotics IQ?

Test your knowledge about antibiotics by taking our interactive quiz.

 

image description

America’s doctors and healthcare facilities offer health products, therapies and treatments that were unimaginable 50 years ago. Continued progress depends on robust innovation and an efficient regulatory system that protects consumers by ensuring that drugs and medical devices are safe and effective.

The Pew Charitable Trusts works to protect the public by advancing solutions to ensure the safety of medical products and services. Our initiatives, including established programs on prescription drug safety, antibiotics and innovation, and Food and Drug Administration modernization, increase both government and corporate accountability. Our campaigns carefully assess health risks, promote safe practices, and strengthen federal laws and regulations. The work is grounded on sound science and pragmatic goals.

Medical Safety News & Resources

The Super Bugs Causing Unmet Need and the Drugs to Fight Them

Issue Brief Apr 9, 2014 Antibiotics and Innovation Project

Testing new antibiotics to treat highly resistant bacterial infections is especially difficult, since only a small number of patients contract such infections or meet the requirements to participate in clinical trials. Following are examples of hard-to-treat pathogens that present the greatest unmet needs today, and the types of drugs that are most likely to address them.

More

Pew Testimony Before The President’s Council of Advisors on Science and Technology

Other Resource Apr 4, 2014 Antibiotics and Innovation Project

The President’s Council of Advisors on Science and Technology held a public meeting on April 4 to discuss the issue of antimicrobial resistance. Drug safety and innovation director Elizabeth Jungman testified on the need to spur the development of new antibacterial drugs.

More

Pew Testimony Before the U.S.-China Economic and Security Review Commission

Other Resource Apr 3, 2014 Drug Safety Project

Allan Coukell, senior director of drugs and medical devices, testified before the U.S.-China Economic and Security Review Commission on the global pharmaceutical supply chain security and the importance of the newly passed Drug Quality and Security Act.

More

Testimony of Elizabeth Jungman on Counterfeit Medicines

Issue Brief Feb 27, 2014 Drug Safety Project

The House Energy and Commerce Subcommittee on Oversight and Investigation held a hearing on Feb 16 entitled "Counterfeit Drugs: Fighting Illegal Supply Chains." Elizabeth Jungman, director of drug safety and innovation testified on counterfeit drugs the importance that newly passed Drug Quality and Security Act will have on the safety of the U.S. pharmaceutical supply chain.

 

More

Case Studies: How Unsafe Drugs Can Reach Patients

Issue Brief Feb 26, 2014 Drug Safety Project

The following case studies illustrate breaches to the pharmaceutical supply chain—the route a drug travels from its raw material origins to the delivery of a finished medicine. These examples, all of which are discussed in Pew Health Group’s report After Heparin: Protecting Consumers from the Risks of Substandard and Counterfeit Drugs, demonstrate the different ways in which contaminated, fake, or otherwise unsafe medicine can reach patients, and underscore the need for reform.

More

Center for Medicare & Medicaid Services Opens Registration for Open Payments

Other Resource Feb 19, 2014 Pew Prescription Project
The federal government’s Centers for Medicare & Medicaid Services yesterday began allowing pharmaceutical and medical device companies to register online for the new “Open Payments” website, authorized under the Physician Payments Sunshine Act to make more transparent the disclosure of financial interactions among physicians. More

Pew Comments to FDA Draft Guidance on 503A

Issue Brief Feb 3, 2014 Drug Safety Project

On January 31, Pew submitted comments to the U.S. Food and Drug Administration in response to draft guidance on the implementation of Title I of the Drug Quality and Security Act and addressed five topics: anticipatory and office stock compounding; quality standards; FDA / state coordination; MOUs to address inordinate interstate shipment of compounded drugs; use of bulk drug substances.

More

MedPage Today: FDA Mulls Faster OK for High-Need Devices

Media Coverage Jan 30, 2014 Medical Device Initiative
The FDA wants to create an expedited approval pathway for high-risk medical devices for unmet needs, saying current tools at its fingertips are ineffective for speedier approvals. More

MRSA, Football, and Industrial Farms

MRSA, or methicillin-resistant Staphylococcus aureus, is a type of bacteria that can infect a person’s skin, bones, lungs, heart, brain, and blood. Unlike common staph, MRSA does not respond to traditional antibiotics such as penicillin, making it more difficult and costlier to treat, and more lethal.
More

Superbug Showdown

Like rivals on the gridiron, superbugs and antibiotic drugs are battling for supremacy. Check out the players on Team Antibiotic and Team Superbug. More

See More
AIP_Hospital_flip1280x840_km_RF